BCAX Bicara Therapeutics Inc. Common Stock
Healthcare$21.68+4.03%ClosedMarket Cap: $1.19B
As of 2026-05-25
Insider Statistics (Q2 2026)
Acquisitions
10
Dispositions
18
Buy/Sell Ratio
0.56
Net Shares
+15,300
Shares Acquired
168,460
Shares Disposed
153,160
Total Bought ($)
$0.00
Total Sold ($)
$9.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Wed May 20 | Mazumdar Claire | director, officer: Chief Executive Officer | Sell | 12,022 | $19.96 | 365,130 |
| Wed May 20 | Mazumdar Claire | director, officer: Chief Executive Officer | Sell | 2,978 | $20.35 | 362,152 |
| Wed May 20 | Mazumdar Claire | director, officer: Chief Executive Officer | Sell | 15,000 | $3.79 | 377,152 |
| Mon May 18 | Cohlhepp Ryan | director, officer: President and COO | Sell | 8,000 | $20.29 | 196,141 |
| Mon May 18 | Cohlhepp Ryan | director, officer: President and COO | Sell | 4,500 | $20.29 | 191,641 |
| Mon May 18 | Cohlhepp Ryan | director, officer: President and COO | Sell | 8,000 | $3.79 | 204,141 |
| Tue May 12 | Schelman William | officer: Chief Medical Officer | Sell | 85,000 | $22.58 | 85,000 |
| Tue May 12 | Schelman William | officer: Chief Medical Officer | Sell | 150,000 | $16.61 | 0 |
| Tue May 12 | Schelman William | officer: Chief Medical Officer | Sell | 25,000 | $16.76 | 0 |
| Tue Apr 28 | Raben David | officer: Chief Medical Officer | Sell | 5,500 | $22.88 | 55,286 |
| Tue Apr 28 | Raben David | officer: Chief Medical Officer | Sell | 5,500 | $3.79 | 60,786 |
| Wed Apr 22 | Hyep Ivan | officer: Chief Financial Officer | Sell | 9,200 | $23.00 | 145,355 |
| Wed Apr 22 | Hyep Ivan | officer: Chief Financial Officer | Sell | 9,200 | $3.79 | 154,555 |
| Mon Apr 20 | Mazumdar Claire | director, officer: Chief Executive Officer | Sell | 15,000 | $23.61 | 362,152 |
| Mon Apr 20 | Mazumdar Claire | director, officer: Chief Executive Officer | Sell | 15,000 | $3.79 | 377,152 |